Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
about
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transitionTumor and stromal-based contributions to head and neck squamous cell carcinoma invasionECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammationCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsEpidermal growth factor signaling in transformed cellsErlotinib-Conjugated Iron Oxide Nanoparticles as a Smart Cancer-Targeted Theranostic Probe for MRIGrape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transitionEpidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinomaEpithelial-mesenchymal transition in prostate cancer: an overview.Dendritic cell-secreted lipocalin2 induces CD8+ T-cell apoptosis, contributes to T-cell priming and leads to a TH1 phenotype.A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1.Soluble E-cadherin: more than a symptom of disease.Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinomaAcidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma modelCrosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.BCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer.Extracellular molecules involved in cancer cell invasionNuclear signaling from cadherin adhesion complexesMolecular parameters of head and neck cancer metastasis.Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.Epithelial-mesenchymal transition in oral squamous cell carcinomaRole of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.Role of ErbB Receptors in Cancer Cell Migration and InvasionRUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis.Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancerVEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinomaEvaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients.A novel orthotopic mouse model of head and neck cancer and lymph node metastasisInsufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis.MT2-MMP induces proteolysis and leads to EMT in carcinomas.Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma.
P2860
Q26799171-8A69AE6E-3E68-4FFF-ACD8-DDC7148A666DQ26825164-E59D763F-7C83-4A6F-9368-ADA7EDCA78AAQ27015979-326E6CCF-0283-4A11-8839-E31255807F24Q27329648-96EAF7A3-5E80-4E0A-8905-0B7CD2A223B3Q28076697-05DD6134-F0C4-4C3F-821B-C264039015E0Q28084034-A93041B5-91EB-4956-9456-5A60FA54C8D3Q30828291-529344D9-D7E8-450C-9B37-49F514B183EEQ31047791-E7370878-84EC-4987-96B7-31C4CFC82153Q33634316-8BDFC6B1-40B7-494C-9E4F-EF56C5820CA4Q33798864-DD536570-363F-4D71-9942-9370535EE527Q33882653-3FC6A71E-A94F-42AF-B20C-A7090C641E71Q34081624-19F4D443-20C0-4249-B0A0-0F6706BECF37Q34107882-F128A4B5-4689-42CE-9320-8A3C66FB5C3AQ34135975-53FAE1EC-73CC-40D3-85B6-376387DB931FQ34279705-8936E3AC-B136-4650-ACD7-7F46FAE600CAQ34525327-CA90B27A-7F40-4FB9-98DA-2DE0486D773FQ34659132-FECF3056-F1AE-468C-8D44-704EE3529E45Q34677454-0503423B-15C8-4B2F-A356-4FCA0D973CDFQ34991219-EAB407FF-1099-4942-8A89-0D5B6ED1C72EQ35237503-EDD24844-3ACB-4044-907E-24DFC5FC1B6AQ35539061-F990D43B-26A7-4F07-BA5C-499C6A3D75EEQ35585465-B7398573-1259-4AD4-BDC1-A82AC9D0035AQ35770840-6483D0EC-5512-42B4-9200-DA7FD70C7417Q35884866-7E9E6085-AE62-4845-83C5-70E8ABD01468Q35934069-9A886496-4645-43DF-9562-CCC01BAA3153Q35996100-E82BAE4A-F1B2-48D6-B2DD-EB8A2D8C8255Q36311027-F8F2B55E-ABCC-4CA1-9A55-187ECD52F986Q36413997-752843C0-E095-468B-83FE-0E11F4936175Q36462450-32C9C2B0-32F3-414F-B220-89268A481ED2Q36467422-C9075D92-694B-4255-B689-23BD2D325B68Q36652148-608AFFA8-4EC8-4C92-8EE9-C5331BFD5671Q36906346-4BFA2F9D-73D5-4EA0-A61C-CDC7016457DAQ37158442-F78BE6AA-0B01-4BF3-B76A-86477345F247Q37206267-DB9EE120-564F-4C45-A9F7-26757F6F6C3AQ37275756-9108C98E-2E89-443F-BDD3-A4956506E740Q37348249-815DF245-E8CF-46BC-8280-29E374FF00FDQ37428089-DD35F3E9-AA10-46F3-B2BC-0BF7F4FA4024Q37565430-3ACFF20C-8F9E-43FC-BA18-2D937BAE811BQ37702322-C6B34277-5931-4C24-BC1F-74CFC2B01611Q37714165-84450CE6-A290-4BCD-B2E7-7922ECEDFED6
P2860
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@en
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@nl
type
label
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@en
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@nl
prefLabel
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@en
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@nl
P2093
P2860
P356
P1476
Activation of EGFR promotes sq ...... ted degradation of E-cadherin.
@en
P2093
Gu-Qing Zeng
Jia-Quan Qu
Jian-Hong Zuo
Jian-Huang Li
Qiu-Yan He
Xin-Hui Li
Xun-Xun Wan
P2860
P304
P356
10.1002/JCB.23175
P577
2011-09-01T00:00:00Z